Merck Tbk PT

Merck Tbk PT Current Liabilities

The Current Liabilities of Merck Tbk PT (MERK.JK) as of Oct 17, 2026 is 245.96 B IDR. In the previous year, Current Liabilities was 126.82 B IDR — a change of 93.94% (higher).

Current Liabilities

245.96 BIDR

YoY

93.94%

Last updated:

Current Liabilities of Merck Tbk PT is 2025 245.96 B IDR. Current Liabilities of Merck Tbk PT was 2024 126.82 B IDR. It decreases by 93.94% higher compared to the previous year.

The Merck Tbk PT Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
388.98 B IDR
Jan 1, 2019
213.16 B IDR
Jan 1, 2020
170.39 B IDR
Jan 1, 2021
152.92 B IDR
Jan 1, 2022
225.09 B IDR
Jan 1, 2023
103.94 B IDR
Jan 1, 2024
126.82 B IDR
Jan 1, 2025
245.96 B IDR
The Merck Tbk PT Current Liabilities history
YEARCurrent LiabilitiesYoY
245.96 BIDR+93.94%
126.82 BIDR+22.01%
103.94 BIDR-53.82%
225.09 BIDR+47.19%
152.92 BIDR-10.25%
170.39 BIDR-20.06%
213.16 BIDR-45.20%
388.98 BIDR+86.80%
208.23 BIDR+42.91%
145.71 BIDR-3.89%
151.60 BIDR+9.84%
138.01 BIDR-15.34%
163.02 BIDR+44.47%
112.84 BIDR+119.09%
51.50 BIDR+9.21%
47.16 BIDR-12.43%
53.86 BIDR+73.83%
30.98 BIDR+13.44%
27.31 BIDR+23.86%
22.05 BIDR-14.85%
25.90 BIDR-40.54%
43.55 BIDR-2.15%
44.51 BIDR+71.07%
26.02 BIDR-35.45%
40.30 BIDR+12.46%
35.84 BIDR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT is a pharmaceutical company based in Jakarta Timur, DKI Jakarta, operating within the Health Care sector. The company, listed on the Indonesian stock exchange with ticker MERK.JK and ISIN ID1000136609, has been publicly traded since its IPO on July 23, 1981. It employs 376 full-time staff and focuses on the development and distribution of pharmaceutical and chemical products. The company operates through three business segments: Biopharma, which covers ethical pharmaceutical products; Consumer Health, which includes over-the-counter products; and Others, which encompasses additional business activities. Merck Tbk PT is committed to providing personalized treatments for serious diseases and supports initiatives related to reproductive health, including enabling individuals to achieve their goal of becoming parents. The company's official website is https://www.merckgroup.com/id-id, where further information about its operations and services can be accessed. As a publicly listed entity, Merck Tbk PT is subject to regulatory disclosures and financial reporting requirements in Indonesia. The company's primary focus remains on delivering healthcare solutions through its pharmaceutical and chemical offerings, targeting both professional medical markets and consumer health needs. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

Current Liabilities of Merck Tbk PT is 245.96 B IDR in 2025.

Current Liabilities of Merck Tbk PT changed from 126.82 B IDR to 245.96 B IDR, representing a 93.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's IDR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Merck Tbk PT historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Merck Tbk PT

All Key Metrics — Merck Tbk PT